Letter eISSN: 2092-6715 to the editor A desirable approach in lieu of the methods used by the authors would have been to use Bland-Altman plots, 3,5,7) which could help not only in evaluating the bias between the mean differences from the two methods but also in identifying the
limit of agreement between the two methods. This limit of agreement could then be assessed for its acceptability (which should be ideally defined a priori based on clinical goals and biological considerations). 5) Other popular alternatives are Passing and Bablok regression 8) and Deming regression. 9) For assessing categorical concordance, Cohen's kappa co-efficient (which takes into account agreement by chance) would have been suitable.
7)
The second concern is about the performance characteristics and quality control of the biochemical assays. Direct LDLC measured by HiSens reagent was validated using a dedicated reagent (BCDR). However, the authors are silent as to whether quality control measures were implemented for the other biochemical tests (viz. glucose, creatinine, triglycerides, high-density lipoprotein cholesterol, and total cholesterol).
In conclusion, the authors investigate the important issue of the difference in LDLC concentrations obtained by the direct and Friedewald methods and its clinical relevance. However, the use of appropriate methodology and clarity on the above-mentioned aspects could have helped in drawing more acceptable inferences and meaningful conclusions in this regard.
